Related Experiment Video

Updated: Jan 9, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K

The impact of pay-for-performance programs on hospitalization risks in subjects with type 1 diabetes mellitus: A

Yun-Kai Yeh1, Fu-Shun Yen2, James Cheng-Chung Wei3

  • 1Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, No.201, Section 2, Shipai Road, Beitou District, Taipei 11217, Taiwan.

Primary Care Diabetes
|November 29, 2025
PubMed

Insights

Pay-for-performance (P4P) programs significantly reduce hospitalizations for type 1 diabetes (T1D) patients. This study shows P4P care lowers risks for various conditions, improving overall health outcomes in T1D individuals.

Area of Science:

  • Health Services Research
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes mellitus (T1D) management requires continuous care to prevent complications.
  • Pay-for-performance (P4P) programs incentivize healthcare providers to improve patient outcomes.
  • Understanding the impact of P4P on T1D hospitalization rates is crucial for healthcare policy.

Purpose of the Study:

  • To evaluate the effect of P4P programs on hospitalization rates among individuals with T1D.
  • To compare the risk of various types of hospitalizations in T1D patients with and without P4P care.

Main Methods:

  • Retrospective cohort study utilizing Taiwan's National Health Insurance Research Database (2006-2018).
  • Propensity score matching to create comparable groups of T1D patients with and without P4P care (625 pairs).
  • Multivariable Cox regression analysis to assess hospitalization risks.

Main Results:

  • P4P participation was linked to a significantly lower risk of all-cause hospitalization (aHR 0.63, 95% CI 0.54-0.73).
  • Reduced hospitalization risks observed for glucose/metabolic disorders, infections, pneumonia, circulatory/respiratory diseases, and mental health.
  • No significant difference in hospitalization risk for hyperglycemic crisis, severe hypoglycemia, or injury.

Conclusions:

  • P4P programs are associated with reduced hospitalization rates in individuals with type 1 diabetes.
  • P4P may improve the management of T1D and its associated comorbidities, leading to fewer hospital admissions.
  • Further research could explore specific P4P mechanisms driving these positive outcomes.
Abstract

Keywords:
HospitalizationPay-for-performanceType 1 diabetes

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

689

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
658
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K